TWC
SAGE

TD Waterhouse Canada’s Sage Therapeutics SAGE Stock Holding History

TD Waterhouse Canada’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-100
Closed -$1.98K – 1786
2023
Q3 		$1.98K Hold
100
– – ﹤0.01% 1498
2023
Q2 		$4.7K Hold
100
– – ﹤0.01% 1404
2023
Q1 		$4.22K Hold
100
– – ﹤0.01% 1406
2022
Q4 		$3.72K Hold
100
– – ﹤0.01% 1405
2022
Q3 		$3.96K Hold
100
– – ﹤0.01% 1395
2022
Q2 		$3.23K Hold
100
– – ﹤0.01% 1468
2022
Q1 		$3.7K Hold
100
– – ﹤0.01% 1504
2021
Q4 		$4.22K Buy
+100
New +$4.19K ﹤0.01% 1483

Other funds holding SAGE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TD Waterhouse Canada's SAGE Position: Q4 2023 in Review

TD Waterhouse Canada sold out of Sage Therapeutics (SAGE) in Q4 2023, closing a stake of 100 shares — an estimated $1.98K sold.

TD Waterhouse Canada first reported a position in SAGE in Q4 2021 and held it in 8 quarters. The position peaked at $4.7K in Q2 2023. 201 funds tracked by Wall St. Rank hold SAGE as of Q4 2023.

  • TD Waterhouse Canada reported no remaining Sage Therapeutics position as of Q4 2023 after selling out during the quarter.
  • TD Waterhouse Canada sold 100 Sage Therapeutics shares in Q4 2023, an estimated $1.98K.
  • TD Waterhouse Canada first reported a position in Sage Therapeutics in Q4 2021 and held it in 8 quarters.
  • TD Waterhouse Canada's Sage Therapeutics position peaked at $4.7K in Q2 2023.
  • 201 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2023.

Based on TD Waterhouse Canada's 13F filing for Q4 2023, filed 12 Feb 2024.